Macroeconomic Woes, Competition Weigh on TMO's Stock Performance

Thermo Fisher (TMO) has been suffering due to a continuous decline in testing sales. Also, competitive headwinds and currency fluctuations continue to dampen top-line growth. The stock carries a Zacks Rank #4 (Sell).Concerning Factors for TMOSince the past few quarters, Thermo Fisher has been experiencing a continuous decline in COVID testing-related demand. During the third quarter of 2024, the Life Science Solution business experienced the biggest impact due to the end of COVID-19. Also, diagnostics and h ...